McClave SA, et al. J Parenter and Enter Nutri 2016;40:159-211
Weimann A, et al. Clin Nutr 2017;36:623–650
Muscaritoli M, Arends J, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutrition 40 (2021) 2898-2913
Maruyama T et al. Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer. Nutrition 2011. 27 146–152.
Lind DS. J Nutr 2004;134:2837S-2841S; discussion 2853S.
Daly MD, Weintraub FN, Shou J,et al. Enternal Nutrition During Multimodality Therapy in Upper Gastrointestinal Cancer Patients. Annals of Surgery 1995; vol.221, No.4, 327-338
Maruyama T., et al., Nutrition 2011;27;146-152
Machon C, et al. Support Care Cancer 2012;20:3129–3135.
Ariaans, et al. Jalving Cancer-drug induced insulin resistance: innocent bystander or unusual suspect. Cancer Treat Rey 2015, 41: 376-384.
Honors M, et al. The role of insulin resistance in the development of muscle wasting during cancer cachexia. J Cachexia Sarcopenia Muscle. 2012;3:5-11.
Hershey, D.S, Importance of glycemic control in cancer patients with diabetes: treatment through end of life. Asia Pac. J. Oncol. Nurs. 2017; 4,313-318
Hershey DS et al. Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis. Asia Pac J Oncol Nurs 2017;4:224-32. 10.4103